Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Hashimoto

Showing results (361-370 of 467) with videos related to

Pageof 47
Sort By:
Biochemical and Biophysical Research Communications|September 20, 2016
The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophreniaMitsuhiro Miyashita, Takuo Watanabe, Tomoe Ichikawa, et al.
JAMA Psychiatry|April 11, 2014
Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individualsDwight Dickinson, Richard E Straub, Joey W Trampush, et al.
Nature Medicine|May 30, 2018
Convergence of placenta biology and genetic risk for schizophreniaGianluca Ursini, Giovanna Punzi, Qiang Chen, et al.
Dementia and Geriatric Cognitive Disorders|October 1, 2010
KIBRA genetic polymorphism influences episodic memory in Alzheimer's disease, but does not show association with disease in a Japanese cohortNoriyuki Hayashi, Hiroaki Kazui, Kouzin Kamino, et al.
Biological Psychiatry|September 14, 2010
Genome-wide association study of schizophrenia in a Japanese populationMasashi Ikeda, Branko Aleksic, Yoko Kinoshita, et al.
Neuroimage. Clinical|December 5, 2017
The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjectsNaoki Hashimoto, Yoichi M Ito, Naohiro Okada, et al.
The International Journal of Neuropsychopharmacology|March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide studyShinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Bjpsych Open|June 3, 2022
Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre studyChika Sumiyoshi, Kazutaka Ohi, Haruo Fujino, et al.
Translational Psychiatry|October 26, 2021
Multiple alterations in glutamatergic transmission and dopamine D2 receptor splicing in induced pluripotent stem cell-derived neurons from patients with familial schizophreniaKana Yamamoto, Toshihiko Kuriu, Kensuke Matsumura, et al.
Psychiatry and Clinical Neurosciences|November 4, 2016
Estimated cognitive decline in patients with schizophrenia: A multicenter studyHaruo Fujino, Chika Sumiyoshi, Yuka Yasuda, et al.
Pageof 47

Showing results (361-370 of 467) with videos related to

Sort By:
Pageof 47
Biochemical and Biophysical Research Communications|September 20, 2016
The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophreniaMitsuhiro Miyashita, Takuo Watanabe, Tomoe Ichikawa, et al.
JAMA Psychiatry|April 11, 2014
Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individualsDwight Dickinson, Richard E Straub, Joey W Trampush, et al.
Nature Medicine|May 30, 2018
Convergence of placenta biology and genetic risk for schizophreniaGianluca Ursini, Giovanna Punzi, Qiang Chen, et al.
Dementia and Geriatric Cognitive Disorders|October 1, 2010
KIBRA genetic polymorphism influences episodic memory in Alzheimer's disease, but does not show association with disease in a Japanese cohortNoriyuki Hayashi, Hiroaki Kazui, Kouzin Kamino, et al.
Biological Psychiatry|September 14, 2010
Genome-wide association study of schizophrenia in a Japanese populationMasashi Ikeda, Branko Aleksic, Yoko Kinoshita, et al.
Neuroimage. Clinical|December 5, 2017
The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjectsNaoki Hashimoto, Yoichi M Ito, Naohiro Okada, et al.
The International Journal of Neuropsychopharmacology|March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide studyShinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Bjpsych Open|June 3, 2022
Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre studyChika Sumiyoshi, Kazutaka Ohi, Haruo Fujino, et al.
Translational Psychiatry|October 26, 2021
Multiple alterations in glutamatergic transmission and dopamine D2 receptor splicing in induced pluripotent stem cell-derived neurons from patients with familial schizophreniaKana Yamamoto, Toshihiko Kuriu, Kensuke Matsumura, et al.
Psychiatry and Clinical Neurosciences|November 4, 2016
Estimated cognitive decline in patients with schizophrenia: A multicenter studyHaruo Fujino, Chika Sumiyoshi, Yuka Yasuda, et al.
Pageof 47